{
    "organizations": [],
    "uuid": "495ec73e7ee22ee9464f6715594ff5084906f224",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-abiomed-q4-gaap-eps-080/brief-abiomed-q4-gaap-eps-0-80-idUSASC09ZGS",
    "ord_in_thread": 0,
    "title": "Abiomed Q4 GAAP EPS $0.80",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "May 3 (Reuters) - Abiomed Inc:\n* ABIOMED ANNOUNCES Q4 FY 2018 REVENUE OF $174 MILLION, UP 40%, AND TOTAL YEAR REVENUE OF $594 MILLION, UP 33%, OVER PRIOR YEAR\n* Q4 GAAP EARNINGS PER SHARE $0.80 * Q4 REVENUE $174.4 MILLION VERSUS I/B/E/S VIEW $164.3 MILLION\n* SEES FY 2019 REVENUE $740 MILLION TO $770 MILLION * Q4 EARNINGS PER SHARE VIEW $0.64 â€” THOMSON REUTERS I/B/E/S Source text for Eikon:\nOur ",
    "published": "2018-05-03T19:32:00.000+03:00",
    "crawled": "2018-05-04T16:36:11.000+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "may",
        "reuters",
        "abiomed",
        "inc",
        "abiomed",
        "announces",
        "q4",
        "fy",
        "revenue",
        "million",
        "total",
        "year",
        "revenue",
        "million",
        "prior",
        "year",
        "q4",
        "gaap",
        "earnings",
        "per",
        "share",
        "q4",
        "revenue",
        "million",
        "versus",
        "view",
        "million",
        "see",
        "fy",
        "revenue",
        "million",
        "million",
        "q4",
        "earnings",
        "per",
        "share",
        "view",
        "thomson",
        "reuters",
        "source",
        "text",
        "eikon"
    ]
}